Loading…

Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy

Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than o...

Full description

Saved in:
Bibliographic Details
Published in:Progress in neuro-psychopharmacology & biological psychiatry 2006-06, Vol.30 (4), p.565-585
Main Authors: Lechin, Fuad, van der Dijs, Bertha, Hernández-Adrián, Gerardo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3
cites cdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3
container_end_page 585
container_issue 4
container_start_page 565
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 30
creator Lechin, Fuad
van der Dijs, Bertha
Hernández-Adrián, Gerardo
description Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.
doi_str_mv 10.1016/j.pnpbp.2005.11.025
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67912294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S027858460500388X</els_id><sourcerecordid>67912294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</originalsourceid><addsrcrecordid>eNqFkd-q1DAQxosonj1Hn0CQ3ujV2ZpJ0qYreHE4_oUDguh1SNLpNkub1KRb2Hf0oczuVvZG9GpmPn4zDN-XZS-AFECgerMrRjfqsaCElAVAQWj5KFtBLeo1p1A9zlaEpr6seXWVXce4I4QAI-xpdgUVZxUDWGW_3vsQVZ8HNXaYz7HIB2yscosQMfjJOwxba3LlJrX1zsahyO-cmvxgjepv87E7ROt7vz2PGjs1Wx-OvcN98Ogab4J1F-Qkj50KgzJ_1HS-yU1v3WnA2TboDMa3-TfscVapz1sf_r46dZj-PTzLnrSqj_h8qTfZj48fvt9_Xj98_fTl_u5hbXjNp7XSJUBNQJsWRFm3TIi6VIS1jHHSbjS2QtecmLbiNWihlGEN0yWpFKGGaMNustfnu2PwP_cYJznYaLDvlUO_j7ISG6B0w_8LggDBakESyM6gCT7GgK0cgx1UOEgg8pi23MlT2vKYtgSQKe209XI5v9cptsvOEm8CXi2AismnNiQbbbxwQnDKKE3cuzOHybXZYpDR2KP9jQ1oJtl4-89HfgPF3s_J</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17173870</pqid></control><display><type>article</type><title>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</title><source>ScienceDirect Freedom Collection</source><creator>Lechin, Fuad ; van der Dijs, Bertha ; Hernández-Adrián, Gerardo</creator><creatorcontrib>Lechin, Fuad ; van der Dijs, Bertha ; Hernández-Adrián, Gerardo</creatorcontrib><description>Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2005.11.025</identifier><identifier>PMID: 16436311</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>5-HT-1A receptors ; 5-HT-1B/D receptors ; Adult and adolescent clinical studies ; Animals ; Behavior - drug effects ; Behavior - physiology ; Biological and medical sciences ; Catecholamines - pharmacology ; Central serotonergic system ; Depression ; Depression and psychotic circuitries ; Dorsal raphe ; Humans ; Major depression and dysthymic depression ; Median raphe ; Medical sciences ; Mood disorders ; Neural Pathways - anatomy &amp; histology ; Neural Pathways - drug effects ; Neural Pathways - physiology ; Neuroendocrinology ; Neuropharmacology ; Neurophysiology ; Pharmacology. Drug treatments ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Raphe Nuclei - anatomy &amp; histology ; Raphe Nuclei - drug effects ; Raphe Nuclei - physiology ; Serotonin Antagonists - pharmacology</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2006-06, Vol.30 (4), p.565-585</ispartof><rights>2005 Elsevier Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</citedby><cites>FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17742322$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16436311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lechin, Fuad</creatorcontrib><creatorcontrib>van der Dijs, Bertha</creatorcontrib><creatorcontrib>Hernández-Adrián, Gerardo</creatorcontrib><title>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.</description><subject>5-HT-1A receptors</subject><subject>5-HT-1B/D receptors</subject><subject>Adult and adolescent clinical studies</subject><subject>Animals</subject><subject>Behavior - drug effects</subject><subject>Behavior - physiology</subject><subject>Biological and medical sciences</subject><subject>Catecholamines - pharmacology</subject><subject>Central serotonergic system</subject><subject>Depression</subject><subject>Depression and psychotic circuitries</subject><subject>Dorsal raphe</subject><subject>Humans</subject><subject>Major depression and dysthymic depression</subject><subject>Median raphe</subject><subject>Medical sciences</subject><subject>Mood disorders</subject><subject>Neural Pathways - anatomy &amp; histology</subject><subject>Neural Pathways - drug effects</subject><subject>Neural Pathways - physiology</subject><subject>Neuroendocrinology</subject><subject>Neuropharmacology</subject><subject>Neurophysiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Raphe Nuclei - anatomy &amp; histology</subject><subject>Raphe Nuclei - drug effects</subject><subject>Raphe Nuclei - physiology</subject><subject>Serotonin Antagonists - pharmacology</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkd-q1DAQxosonj1Hn0CQ3ujV2ZpJ0qYreHE4_oUDguh1SNLpNkub1KRb2Hf0oczuVvZG9GpmPn4zDN-XZS-AFECgerMrRjfqsaCElAVAQWj5KFtBLeo1p1A9zlaEpr6seXWVXce4I4QAI-xpdgUVZxUDWGW_3vsQVZ8HNXaYz7HIB2yscosQMfjJOwxba3LlJrX1zsahyO-cmvxgjepv87E7ROt7vz2PGjs1Wx-OvcN98Ogab4J1F-Qkj50KgzJ_1HS-yU1v3WnA2TboDMa3-TfscVapz1sf_r46dZj-PTzLnrSqj_h8qTfZj48fvt9_Xj98_fTl_u5hbXjNp7XSJUBNQJsWRFm3TIi6VIS1jHHSbjS2QtecmLbiNWihlGEN0yWpFKGGaMNustfnu2PwP_cYJznYaLDvlUO_j7ISG6B0w_8LggDBakESyM6gCT7GgK0cgx1UOEgg8pi23MlT2vKYtgSQKe209XI5v9cptsvOEm8CXi2AismnNiQbbbxwQnDKKE3cuzOHybXZYpDR2KP9jQ1oJtl4-89HfgPF3s_J</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Lechin, Fuad</creator><creator>van der Dijs, Bertha</creator><creator>Hernández-Adrián, Gerardo</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20060601</creationdate><title>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</title><author>Lechin, Fuad ; van der Dijs, Bertha ; Hernández-Adrián, Gerardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>5-HT-1A receptors</topic><topic>5-HT-1B/D receptors</topic><topic>Adult and adolescent clinical studies</topic><topic>Animals</topic><topic>Behavior - drug effects</topic><topic>Behavior - physiology</topic><topic>Biological and medical sciences</topic><topic>Catecholamines - pharmacology</topic><topic>Central serotonergic system</topic><topic>Depression</topic><topic>Depression and psychotic circuitries</topic><topic>Dorsal raphe</topic><topic>Humans</topic><topic>Major depression and dysthymic depression</topic><topic>Median raphe</topic><topic>Medical sciences</topic><topic>Mood disorders</topic><topic>Neural Pathways - anatomy &amp; histology</topic><topic>Neural Pathways - drug effects</topic><topic>Neural Pathways - physiology</topic><topic>Neuroendocrinology</topic><topic>Neuropharmacology</topic><topic>Neurophysiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Raphe Nuclei - anatomy &amp; histology</topic><topic>Raphe Nuclei - drug effects</topic><topic>Raphe Nuclei - physiology</topic><topic>Serotonin Antagonists - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lechin, Fuad</creatorcontrib><creatorcontrib>van der Dijs, Bertha</creatorcontrib><creatorcontrib>Hernández-Adrián, Gerardo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lechin, Fuad</au><au>van der Dijs, Bertha</au><au>Hernández-Adrián, Gerardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>30</volume><issue>4</issue><spage>565</spage><epage>585</epage><pages>565-585</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>16436311</pmid><doi>10.1016/j.pnpbp.2005.11.025</doi><tpages>21</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2006-06, Vol.30 (4), p.565-585
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_67912294
source ScienceDirect Freedom Collection
subjects 5-HT-1A receptors
5-HT-1B/D receptors
Adult and adolescent clinical studies
Animals
Behavior - drug effects
Behavior - physiology
Biological and medical sciences
Catecholamines - pharmacology
Central serotonergic system
Depression
Depression and psychotic circuitries
Dorsal raphe
Humans
Major depression and dysthymic depression
Median raphe
Medical sciences
Mood disorders
Neural Pathways - anatomy & histology
Neural Pathways - drug effects
Neural Pathways - physiology
Neuroendocrinology
Neuropharmacology
Neurophysiology
Pharmacology. Drug treatments
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Raphe Nuclei - anatomy & histology
Raphe Nuclei - drug effects
Raphe Nuclei - physiology
Serotonin Antagonists - pharmacology
title Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T02%3A01%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dorsal%20raphe%20vs.%20median%20raphe%20serotonergic%20antagonism.%20Anatomical,%20physiological,%20behavioral,%20neuroendocrinological,%20neuropharmacological%20and%20clinical%20evidences:%20Relevance%20for%20neuropharmacological%20therapy&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Lechin,%20Fuad&rft.date=2006-06-01&rft.volume=30&rft.issue=4&rft.spage=565&rft.epage=585&rft.pages=565-585&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2005.11.025&rft_dat=%3Cproquest_cross%3E67912294%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17173870&rft_id=info:pmid/16436311&rfr_iscdi=true